NOVEL AMINOALCOHOL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
申请人:SCHWINK Lothar
公开号:US20090082391A1
公开(公告)日:2009-03-26
The invention relates to aminoalcohol-substituted aryldihydroisoquinolinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one aminoalcohol-substituted aryldihydroisoquinolinone of the invention or its derivative, and the use of the aminoalcohol-substituted aryldihydroisoquinolinones of the invention and their derivatives as MCH antagonists.
Aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
申请人:Schwink Lothar
公开号:US08501771B2
公开(公告)日:2013-08-06
The invention relates to aminoalcohol-substituted aryldihydroisoquinolinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one aminoalcohol-substituted aryldihydroisoquinolinone of the invention or its derivative, and the use of the aminoalcohol-substituted aryldihydroisoquinolinones of the invention and their derivatives as MCH antagonists.
[EN] NOVEL AMINOALCOHOL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS<br/>[FR] NOUVELLES ARYLDIHYDROISOQUINOLINONES A SUBSTITUTION AMINO-ALCOOL, PROCEDE POUR LES PREPARER ET LEUR UTILISATION EN TANT QUE MEDICAMENTS
申请人:SANOFI AVENTIS
公开号:WO2007093366A1
公开(公告)日:2007-08-23
[EN] The invention relates to aminoalcohol-substituted aryldihydroisoquinolinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one aminoalcohol-substituted aryldihydroisoquinolinone of the invention or its derivative, and the use of the aminoalcohol- substituted aryldihydroisoquinolinones of the invention and their derivatives as MCH antagonists. [FR] L'invention concerne des aryldihydroisoquinolinones à substitution amino-alcool et leurs dérivés, ainsi que leurs sels tolérés physiologiquement et leurs dérivés présentant une fonctionnalité sur le plan physiologique. L'invention concerne également la préparation de tels composés, des médicaments comprenant au moins une aryldihydroisoquinolinone à substitution amino-alcool de l'invention ou son dérivé, et l'utilisation des aryldihydroisoquinolinones à substitution amino-alcool de l'invention et de leurs dérivés en tant qu'agonistes de MCH.